ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,149.78
0.16%
Dow Jones
42,992.21
-0.77%
Gold vs US Dollar
2,622.18
0.00%
Brent Oil
73.44
0.00%
Bitcoin
94,792.41
-0.37%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Vivoryon Therapeut (VVY) Share Price

VVY Vivoryon Therapeut

2.03
0.06 (3.05%)
27 Dec 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Vivoryon Therapeut EU:VVY Euronext Ordinary Share NL00150002Q7 
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.06 3.05 2.03 2.015 2.075 2.095 1.97 1.97 160,693 16:40:00   
 Type  Size  Price  Time  Units 
  1 2.03 16:35:21 EUR
 
Recent News
DateTimeSource
HeadlineMore VVY News
09/12/202406:00UKREGVivoryon Therapeutics N.V. Presents Topline Phase 2 Data from VIVA-MIND Strongly Supporting Varoglutamstat’s Potential to Improve Kidney Function
04/12/202406:00UKREGVivoryon Therapeutics N.V. to Report Q3 2024 Financial Results and Operational Progress on December 10, 2024
26/10/202407:30UKREGVivoryon Therapeutics N.V. Presents Outstanding Phase 2b Results of Varoglutamstat on Kidney Function at ASN Kidney Week 2024
11/10/202413:20UKREGVivoryon Therapeutics N.V. Announces Late-breaking Oral Presentation at the American Society of Nephrology Kidney Week 2024
01/10/202405:00UKREGVivoryon Therapeutics N.V. Shares Highlights from Virtual Kidney Disease KOL Event
12/09/202405:00UKREGVivoryon Therapeutics N.V. Reports H1 2024 Progress Marked by Compelling Kidney Function Data and Execution of Strategy to Advance Varoglutamstat in Kidney Disease
05/09/202416:12UKREGVivoryon Therapeutics N.V. Announces Completion of Share Capital Reduction and Change to Articles of Association
Period
Draw mode
Data Downloads for VVY

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Vivoryon Therapeut Articles

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads